Latest immunotherapy news
FDA Approves Breyanzi for Relapsed, Refractory Marginal Zone Lymphoma
posted December 15th
by modernClinician Editorial Team
by modernClinician Editorial Team
Timing of Immune Checkpoint Inhibitor Administration Affects Small Cell Lung Cancer Survival
posted December 8th
by modernClinician Editorial Team
by modernClinician Editorial Team
Rocatinlimab Yields Significant Improvements in Atopic Dermatitis
posted December 5th
by modernClinician Editorial Team
by modernClinician Editorial Team
Tezepelumab Can Help Reduce Oral Corticosteroid Use in Severe Uncontrolled Asthma
posted December 4th
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
Drug Interactions Reducing Contraceptive Effectiveness Common in Epilepsy .jpg)
Most Specialty Oral Anticancer Meds for Blood Cancers Are Initially Rejected by Insurers 
Holding DMARDs at Time of COVID-19 Vaccine Not Warranted in Those With Inflammatory Arthritis 
1 in 3 With Lupus Take Supplements, Medications With Potential for Interactions Related Articles
Blinatumomab Improves Event-Free Survival in Children With High-Risk B-Cell ALL 
Rheumatic Immune-Related AEs With Immune Checkpoint Inhibitors More Severe Than Previously Reported 
Thymic Radiation Linked to Worse Outcomes in Patients With NSCLC 
Preoperative Chemo + Immunotherapy Combo Shrinks Head, Neck Cancer Tumors Monthly Specialist Briefings
Stay Connected
